INTRAVENOUS ETIDRONATE FOR SPINAL CORD DYSFUNCTION DUE TO PAGET'S DISEASE

S Charhon(Inserm), Pierre J. Meunier, A. Valentin-Opran(Inserm), M. C. Chapuy

The Lancet

February 1, 1982

10.1016/s0140-6736(82)91411-8

Cited by 24

Related Papers

RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES

|Journal of Bone and Joint Surgery|2002|1.3k

Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.

|BMJ|1980|585

Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects

|Journal of Bone and Joint Surgery|2006|447

Clinical Evaluation of Recombinant Human Bone Morphogenetic Protein-2

|Clinical Orthopaedics and Related Research|2002|290

Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia

|Cancer|1983|210